Life Science

Più recente

281 a 290 di 297
  • First comprehensive regulations on medical devices in China Accesso limitato

    Articolo

    Ultima consultazione: 26 August 2008 / Inviato: 26 August 2008

    The regulatory regime in China for medical devices will soon change substantively as the State Food and Drug Administration has released its proposed Revised Rules on Administration of Production Quality of Medical Devices (Draft for Comments).

  • Lilly v HGS: A cloud for HGS, but a silver lining for BioPharma Accesso limitato

    Articolo

    Ultima consultazione: 10 February 2010 / Inviato: 05 August 2008

    Human Genome Sciences` European patent (UK) for Neutrokine-á and antibodies thereto was invalidated on Thursday 31 July 2008 by Mr Justice Kitchin on the ground that it lacked industrial applicability. This is an important decision on the patenting of biotechnology and is also one of the few English cases to consider the industrial applicability ground for patentability. The decision was upheld by the Court of Appeal in February 2010.

  • Third amendment to PRC patent law: impact on R&D activities Accesso limitato

    Articolo

    Ultima consultazione: 12 May 2008 / Inviato: 12 May 2008

    Patents from inventions developed in China will have to be filed first in China and in Chinese.

  • Dutch Tax: the patent income tax regime Accesso limitato

    Articolo

    Ultima consultazione: 12 May 2008 / Inviato: 12 May 2008

    Applying the Dutch patent income tax regime could lower a company`s tax burden: a significant amount of patent income will then effectively be taxed at only 10 per cent.

  • French Finance Act 2008: modified R&D and patent tax regime Accesso limitato

    Articolo

    Ultima consultazione: 12 May 2008 / Inviato: 12 May 2008

    The French Finance Act 2008 has reformed in a very beneficial way the tax regimes applicable to the R&D tax credit and to patents owned by certain companies.

  • Pharmaceutical companies in France fined for unlawful advertising Accesso limitato

    Articolo

    Ultima consultazione: 20 March 2008 / Inviato: 20 March 2008

    The Economic Committee of Health Products now has the power to fine pharmaceutical companies and it appears determined to exercise its prerogatives.

  • UK Budget 2008: confirmation of increased R&D tax relief Accesso limitato

    Articolo

    Ultima consultazione: 20 March 2008 / Inviato: 20 March 2008

    In UK Budget 2008, the Chancellor confirmed that increases to the rates of R&D tax relief for all companies first announced in Budget 2007 will go ahead.

  • Liberalisation of German pharmacy market: update Accesso limitato

    Articolo

    Ultima consultazione: 06 July 2007 / Inviato: 06 July 2007

    Celesio AG, a pharmaceutical trader has acquired a 90 per cent stake in DocMorris, the Dutch based internet pharmacy retailer for a reported €200m.

  • M&A and licensing: two journeys - same destination Accesso limitato

    Articolo

    Ultima consultazione: 11 May 2007 / Inviato: 11 May 2007

    Simmons & Simmons` latest report examines how pharmaceutical M&A and licensing strategies are developing in light of increased competition in the market.

  • Compensation for employee inventors in Germany Accesso limitato

    Articolo

    Ultima consultazione: 17 April 2007 / Inviato: 17 April 2007

    The German Employees` Invention Act governs the ownership of inventions made by employees and compensation to be paid by employers to their employees for those inventions.

281 a 290 di 297